MAY 21, 2019 10:17 PM PDT

A New Class Of Depression Medication

WRITTEN BY: Abbie Arce

The National Institutes of Health (NIH) estimate that over 17 million adults in the US have had at least one major depressive episode. At any given time, another 24.4 million adults suffer from Post-Traumatic Stress Disorder (PTSD). 

All of the drug therapies available for depression today focus on suppressing the symptoms of the disorder. In the US, even with the highest percentage of the population on antidepressants than anywhere else in the world, the effectiveness of these medications is often scrutinized.

What if instead of suppressing the symptoms, we could develop a medication to help people deal with the stressful situations that cause depression and PTSD before they develop. 

In 2014, neuroscientist Rebecca Brachman and her team may have stumbled upon a drug that does just that. This newly discovered class of drugs works by increasing a person's stress resilience. The idea is that these drugs would boost a person's ability to handle extreme stressors much in the way that a vitamin might raise a person's immune response. 

In the above video, Brachman goes into detail about her incredible discovery and what it might mean for the future of treating PTSD and depression. 


Sources: TEDNational Institute of Mental Health

About the Author
  • Abbie is an AFAA certified personal trainer and fitness instructor with an interest in all things health-science. She has recently graduated with her BS in Applied Sport and Exercise Science from Barry University in Miami. Next, she intends to earn an MPH with a focus in Epidemiology.
You May Also Like
FEB 22, 2021
Microbiology
A Nasal Spray That Seems to Prevent the Spread of COVID-19
FEB 22, 2021
A Nasal Spray That Seems to Prevent the Spread of COVID-19
Reporting in Science, researchers have created an antiviral nasal spray that could help us get the COVID-19 pandemic und ...
MAR 09, 2021
Cannabis Sciences
Cannabis Alleviates Neuropathic Pain from Chemotherapy
MAR 09, 2021
Cannabis Alleviates Neuropathic Pain from Chemotherapy
Neuropathic pain from oxaliplatin-based chemotherapy regimens occurs in up to 90% of patients, and continued exposure to ...
APR 27, 2021
Drug Discovery & Development
Natural Remedy Better than Steroids For COVID-19 Smell Loss
APR 27, 2021
Natural Remedy Better than Steroids For COVID-19 Smell Loss
An international group of olfactory experts have recommended against the use of steroid treatments for loss of smell rel ...
MAY 06, 2021
Drug Discovery & Development
Are Hallucinations Necessary for Psychedelics to Treat Depression?
MAY 06, 2021
Are Hallucinations Necessary for Psychedelics to Treat Depression?
Many who work with psychedelics say that hallucinations, or psychedelic experiences, are an integral part of psychedelic ...
MAY 17, 2021
Immunology
Understanding Inflammation: A Faster, Easier Way to Detect Cytokines in Cells
MAY 17, 2021
Understanding Inflammation: A Faster, Easier Way to Detect Cytokines in Cells
Inflammation, a process that was meant to defend our body from infection, has been found to contribute to a wide range o ...
JUN 10, 2021
Plants & Animals
Antibiotics Fight Mysterious Coral Disease
JUN 10, 2021
Antibiotics Fight Mysterious Coral Disease
Coral reefs besieged by climate change and pollutants have a new line of defense against disease-an antibiotic commonly ...
Loading Comments...